Applications Now Being Accepted to the Francis S. Collins Scholars Program

The Neurofibromatosis Therapeutic Acceleration Program (NTAP/ is dedicated to the advancement of research that will improve outcomes for patients with neurofibromatosis type 1 (NF1).  A major need to accomplish this mission is the training and support of clinician scientists who are dedicated to NF1. NTAP launched the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research to address this need.

The deadline for application submissions is November 22, 2019. Successful applicants will be notified by January 8, 2019 and the tenure starts in July 1, 2020. NTAP looks forward to receiving applications from excellent candidates meeting the eligibility requirements from around the world, across any discipline that has relevance to NF1.

Interested applicants should download the following:

Please contact Sharad Verma at or Rhonda Jackson at, for any questions or concerns